| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/06/2011 | EP2304047A1 Antibodies specific to heterodimers of bcl-2 family and uses thereof |
| 04/06/2011 | EP2304033A2 Functionalized polypeptides |
| 04/06/2011 | EP2304029A1 Surface display of whole antibodies in eukaryotes |
| 04/06/2011 | EP2304024A2 Avian reoviridae |
| 04/06/2011 | EP2303926A1 Immunogenic memapsin 2 -secretase peptides and methods of use |
| 04/06/2011 | EP2303925A2 Pigf-1 assay and kits and components thereof |
| 04/06/2011 | EP2303924A2 Lm-antibodies, functional fragments, lm-1 target antigen, and methods for making and using same |
| 04/06/2011 | EP2303923A1 Human cytomegalovirus neutralising antibodies and use thereof |
| 04/06/2011 | EP2303921A2 Mutated netrin-4 proteins, fragments thereof and their uses as drugs |
| 04/06/2011 | EP2303920A2 AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES |
| 04/06/2011 | EP2303912A1 Cdca1 epitope peptides and vaccines containing the same |
| 04/06/2011 | EP2303407A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells |
| 04/06/2011 | EP2303325A2 Inhibition of emmprin to treat multiple sclerosis |
| 04/06/2011 | EP2303230A2 Methods and compositions for enhanced delivery of macromolecules |
| 04/06/2011 | EP1838737B1 Binding proteins specific for human matriptase |
| 04/06/2011 | EP1721157B1 Use of antibodies to tweak for the treatment of stroke |
| 04/06/2011 | EP1709081B1 Fusion polypeptides capable of activating receptors |
| 04/06/2011 | EP1291424B1 Gasc1 gene |
| 04/06/2011 | CN1774447B S. pneumoniae antigens |
| 04/06/2011 | CN102007414A Method and kit for detection of anti-avibacterium paragallinarum antibody |
| 04/06/2011 | CN102007147A Anti-cd27 antibody |
| 04/06/2011 | CN102007146A Methods for manufacturing a polyclonal protein |
| 04/06/2011 | CN102006886A Therapeutic use of anti-tweak receptor antibodies |
| 04/06/2011 | CN102002503A Fungus resistant plants and their uses |
| 04/06/2011 | CN102002480A Anti-H3N2 swine influenza virus hemagglutinin protein monoclonal antibody, hybridoma cell strain and antigen capturing ELISA kit |
| 04/06/2011 | CN102002104A Anti-VEGF monoclonal antibody and medicinal composition containing same |
| 04/06/2011 | CN102002103A Pesticide trichlorfon-resistant specific antibody |
| 04/06/2011 | CN102002102A Body weight modulators, corresponding nucleic acids and proteins, and their use for diagnosis and therapy |
| 04/06/2011 | CN102002048A Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 04/06/2011 | CN101619318B Application of glyphosate-resistant gene |
| 04/06/2011 | CN101337990B Humanized neutralizing antibody against rabies virus, method for preparing same and use |
| 04/06/2011 | CN101306200B Preparation method of hepatitis b human immunoglobulin for intravenous injection |
| 04/06/2011 | CN101130765B Reagent kit for detecting syncytial virus of respiratory passage |
| 04/06/2011 | CN101035810B Modulators of hepatocyte growth factor activator |
| 04/05/2011 | US7919672 Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 04/05/2011 | US7919607 Nucleic acids encoding humanized anti-tag 72 CC49 antbodies |
| 04/05/2011 | US7919606 Biological products |
| 04/05/2011 | US7919595 Antibodies to interferon-like protein Zcyto21(IL29) |
| 04/05/2011 | US7919594 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders |
| 04/05/2011 | US7919593 Blocks binding to Notch receptor; surface plasmon resonance |
| 04/05/2011 | US7919588 Netrin receptors |
| 04/05/2011 | US7919314 Process for the production of monoclonal antibodies |
| 04/05/2011 | US7919273 Structural variants of antibodies for improved therapeutic characteristics |
| 04/05/2011 | US7919270 Mammalian expression system |
| 04/05/2011 | US7919269 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/05/2011 | US7919257 Method for selecting a single cell expressing a heterogeneous combination of antibodies |
| 04/05/2011 | US7919255 Assessment of skeletal growth using measurements of NT-CNP peptides |
| 04/05/2011 | US7919248 For allergy such as asthma; modulating interleukin (IL)-13 expression |
| 04/05/2011 | US7919103 Compound and method for regulating plasminogen activation and cell migration |
| 04/05/2011 | US7919098 ErbB-3 based methods and compositions for treating neoplasms |
| 04/05/2011 | US7919095 comprising variable heavy chain region and variable light chain region; encodes by nucleotide sequence; specifically binding Interleukin-6; biodrug treating diseases and disorders associated autoimmune disease rheumatoid arthritis, cancer of carcinoma, breast cancer, prostate cancer, lymphoma |
| 04/05/2011 | US7919093 Roles for dual endothelin-1/angiotensin II receptor (Dear) in hypertension and angiogenesis |
| 04/05/2011 | US7919092 Notch receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
| 04/05/2011 | US7919090 Antibody therapy |
| 04/05/2011 | US7919089 Pharmaceutical composition comprising a bispecific antibody for EpCAM |
| 04/05/2011 | US7919087 Immunoglobulin fusion fo use indiagnosis, treatment and prevention of cell proliferative, autoimmune, blood and nervous system disorders |
| 04/05/2011 | US7919086 has a higher cell growth-inhibiting activity via an antibody-dependent cell-mediated cytotoxicity (ADCC) activity and a complement-dependent cytotoxicity (CDC) activity |
| 04/05/2011 | US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL) |
| 04/05/2011 | US7919083 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/05/2011 | US7919076 PH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 04/05/2011 | CA2436402C Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies |
| 04/05/2011 | CA2429027C Antibodies against human receptor h4-1bb |
| 03/31/2011 | WO2011038290A2 Neutralizing antibodies to hiv-1 and their use |
| 03/31/2011 | WO2011037791A1 Antagonists of pcsk9 |
| 03/31/2011 | WO2011037522A1 Separation system and method |
| 03/31/2011 | WO2011037271A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 03/31/2011 | WO2011037262A1 Hybridoma producing anti-methylated dna antibody and utilization of same |
| 03/31/2011 | WO2011037227A1 Agent for prevention of atherosclerosis |
| 03/31/2011 | WO2011037160A1 Antibody capable of recognizing hla class i |
| 03/31/2011 | WO2011037158A1 Modified antibody constant regions |
| 03/31/2011 | WO2011036460A1 Disulfide stabilised multivalent antibodies |
| 03/31/2011 | WO2011036440A1 Antagonists of dsg2 for treatment of cancer |
| 03/31/2011 | WO2011036435A1 Anti-veev humanized antibody |
| 03/31/2011 | WO2011036183A2 Anti-cd33 antibodies and use thereof for immunotargeting in treating cd33-associated illnesses |
| 03/31/2011 | WO2011036118A1 Treating cancer by modulating mex-3 |
| 03/31/2011 | WO2011035884A1 Process for producing molecules containing specialized glycan structures |
| 03/31/2011 | WO2011035465A1 Specific binding proteins and uses thereof |
| 03/31/2011 | WO2011035456A1 Method of acquiring proteins with high affinity by computer aided design |
| 03/31/2011 | WO2011015333A3 Targeting of bone marrow neovasculature |
| 03/31/2011 | WO2011000962A3 Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means |
| 03/31/2011 | WO2010139469A3 Antibodies against human ccn1 and uses thereof |
| 03/31/2011 | WO2010126670A3 Compositions and methods for screening and using compounds antagonizing spore-surface interactions |
| 03/31/2011 | WO2010126278A3 Humanized nsg mouse, method of producing the same and use thereof |
| 03/31/2011 | WO2010114312A3 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same |
| 03/31/2011 | WO2010111360A3 Diagnosis of ciliopathies |
| 03/31/2011 | WO2010111299A3 Synthetic antibodies |
| 03/31/2011 | WO2010069331A3 Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders |
| 03/31/2011 | US20110077384 Protein refolding method |
| 03/31/2011 | US20110077383 Hinge domain engineering |
| 03/31/2011 | US20110077170 Hpiv-2 variants and their medical applications |
| 03/31/2011 | US20110076763 Neoplasm specific antibodies and uses thereof |
| 03/31/2011 | US20110076752 Antibody library display by yeast cell plasma membrane |
| 03/31/2011 | US20110076730 Microbial synthesis of d-1,2,4-butanetriol |
| 03/31/2011 | US20110076723 Antibody-peptide fused synergibody |
| 03/31/2011 | US20110076722 Stable multivalent antibody |
| 03/31/2011 | US20110076708 Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions |
| 03/31/2011 | US20110076705 Compositions and methods for early pregnancy diagnosis |
| 03/31/2011 | US20110076704 Method for diagnosing alzheimer's disease using serum glycoprotein as biomarker |
| 03/31/2011 | US20110076700 Anti-crp antibody and utilization of the same |